BFD-96551-35038
4 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 224 / VA
- Registered
- 2021-08-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
FXC-12060-28885
Child or adolescent in my care · Male · 2022-05-16
Timeline
-
2021-03-15
Dose 1 — Moderna
-
2021-04-12
Dose 2 — Moderna
-
2021-08-05
Registered in v-safe
- 2021-10-11
-
2021-11-15
Dose 3 — Moderna
- 2021-11-15
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
-
2021-12-06
Survey response — day 21, dose 3MedDRA: Fatigue, Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Stuffy nose, nasal drainage, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-02-14
- 2022-05-16
-
2022-09-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-15
- 2022-11-15
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Moderna | No |
| 2 | 2021-04-12 | Moderna | No |
| 3 | 2021-11-15 | Moderna | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 21, dose 3
Symptoms: Stuffy nose, nasal drainage, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release